Hollister’s CEO Gives Investors an Inside Look at the Company Set to Shine in the World’s Largest Cannabis Market
TCI host Alyssa Boston (Miss Universe Canada 2019 + Cannabis Crusader) sat down with Hollister Biosciences (CSE: HOLL) (FRA: HOB) CEO Carl Saling to discuss the company’s goals for 2020 and beyond.
Hollister Biosciences is a vertically integrated cannabis and hemp company based in Hollister, California. The company’s vision is to be the most sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products.
Hollister operates in the world’s largest cannabis market and the company differentiates itself by using a vertically integrated, high margin business model that controls every aspect of the cannabis supply chain.
Carl believes that high margin brands are the key to success in the cannabis industry and his company is focused specifically on THC cannabis and CBD rich industrial hemp.
The Hollister CEO goes on to discuss the company’s current portfolio of products as well as its planned pipeline of new and innovative high margin brands.
In 2020, Hollister will be focused on profitability, increasing revenues, growing its portfolio of brands, continued innovation and overall expansion.
When asked what the major drivers for success in the 2020 cannabis industry would be, the Hollister CEO said the following:
“2020 is going to be a major transition year for the cannabis industry. There are many companies that spent way too much money [in 2019] and didn’t focus on building their brand and ultimately revenue. A lot of companies spent a ton of money on non-revenue generating activities as well as having a huge c-suite and that’s something Hollister will never do.”
Enjoy the video and make sure to follow Hollister on social media via the links below!
Learn more about Hollister: Corporate Profile | Website | IR Website | Investor Deck | HOLL Chart
Follow Hollister on Social Media: Facebook | Instagram | Twitter | LinkedIn
🚨 The Most Anticipated U.S. MSO IPO of 2020 is Drawing Near
📢 The Cannabis Sector is Long Overdue for a High-Profile IPO
⌛️ The Wait is Nearly Over, TCI’s MSO IPO of 2020 is Almost Here
📗 Get Your Copy of The Ultimate Cannabis Investing Guide
Join the Discussion in the TCI Investor Group
Hollister Biosciences is a paid client of The Cannabis Investor.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
Read More:
Featured ArticlesCannabis Stock NewsCannabis Industry ArticlesTechnical Analysis ArticlesWatch Cannabis Stock Videos